CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,000 | -34.2% | 61,093 | -0.8% | 0.01% | -33.3% |
| Q2 2022 | $111,000 | -10.5% | 61,571 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $124,000 | +72.2% | 61,571 | +131.7% | 0.01% | +80.0% |
| Q4 2021 | $72,000 | -37.4% | 26,571 | +3.1% | 0.01% | -50.0% |
| Q3 2021 | $115,000 | -22.8% | 25,771 | 0.0% | 0.01% | -23.1% |
| Q2 2021 | $149,000 | -15.3% | 25,771 | +3.1% | 0.01% | -27.8% |
| Q1 2021 | $176,000 | +363.2% | 25,000 | +3334.1% | 0.02% | +28.6% |
| Q1 2018 | $38,000 | -19.1% | 728 | +4.3% | 0.01% | -22.2% |
| Q4 2017 | $47,000 | -19.0% | 698 | 0.0% | 0.02% | -5.3% |
| Q3 2017 | $58,000 | -20.5% | 698 | -98.9% | 0.02% | +216.7% |
| Q3 2011 | $73,000 | – | 61,093 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |